17-alpha-hydroxyprogesterone has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diederich, S; Koetz, KR; Quinkler, M; van Rossum, EF; Ventz, M | 1 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Bone Loss, Osteoclastic
Article | Year |
---|---|
BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Androstenedione; Bone Density; Bone Resorption; Collagen; Collagen Type I; Cross-Sectional Studies; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Middle Aged; Peptides; Polymorphism, Genetic; Prospective Studies; Receptors, Glucocorticoid | 2013 |